Association Between Urticarial Vasculitis and Lymphoma
Urticarial vasculitis has a recognized but uncommon association with hematologic malignancies including lymphoma, particularly in adults over 50 with persistent or refractory lesions, and requires systematic evaluation for underlying malignancy when hypocomplementemia, cytopenias, or atypical features are present 1, 2.
Understanding the Association
The relationship between urticarial vasculitis and lymphoma is bidirectional and clinically significant:
- Myeloid neoplasms show stronger associations than lymphoid malignancies, though lymphoproliferative disorders can present with vasculitic features 1
- Hypocomplementemic urticarial vasculitis (HUV) carries increased malignancy risk compared to normocomplementemic forms 2
- Vasculitis may precede, occur simultaneously with, or complicate the malignancy 1
- While most lymphoma-associated vasculitis is cutaneous, systemic and even fulminant presentations can occur 3
Red Flags Requiring Malignancy Workup
In adults over 50 with persistent or refractory urticarial vasculitis, evaluate for malignancy when these features are present:
- Marked hypocomplementemia (particularly low C4 with C3 depression) 2
- Unexplained cytopenias (thrombocytopenia, anemia, leukopenia) 2, 1
- Hepatosplenomegaly on examination 2
- Dual autoantibody positivity 1
- Poor response to standard immunosuppression 1
- Constitutional symptoms (fever, weight loss, night sweats)
- Macrocytic anemia (consider VEXAS syndrome) 1, 4
Recommended Evaluation Algorithm
Initial laboratory assessment should include 5, 6:
- Complete blood count with differential
- Comprehensive metabolic panel
- Erythrocyte sedimentation rate and C-reactive protein
- Complement levels (C3, C4) - critical for risk stratification
- Antinuclear antibodies
- Anti-C1q antibodies (if hypocomplementemic) 7
- Serum protein electrophoresis with immunofixation (to detect paraproteinemia) 8, 1
When red flags are present, proceed with:
- Hematology consultation
- Flow cytometry for lymphoproliferative disorders 2
- Bone marrow biopsy if cytopenias or abnormal peripheral smear
- CT chest/abdomen/pelvis for lymphadenopathy or organomegaly
- Consider genetic testing for VEXAS syndrome in refractory cases with macrocytic anemia 1, 4
Critical Diagnostic Considerations
Skin biopsy remains the gold standard for confirming urticarial vasculitis, showing leukocytoclastic vasculitis with fibrinoid necrosis 7. However, many physicians do not perform it, leading to misdiagnosis as chronic spontaneous urticaria 5. The diagnostic algorithm from international guidelines emphasizes that wheals lasting >24 hours should prompt biopsy evaluation 8.
A recent case report highlights atypical presentations: a 55-year-old with hypocomplementemic vasculitis, thrombocytopenia, and no urticarial lesions was found to have CD5-negative, CD19-positive B-cell lymphoproliferative disorder 2. This underscores that vasculitic lesions without classic urticaria can still represent UV associated with malignancy.
Clinical Pitfalls to Avoid
- Do not dismiss persistent lesions as simple chronic urticaria without confirming wheal duration and considering biopsy 5
- Hypocomplementemia is not just a laboratory curiosity - it signals higher risk for systemic disease and malignancy 2, 7
- Thrombocytopenia in UV is particularly concerning for underlying hematologic malignancy 2
- In patients with autoimmune background (like pemphigus, lupus), new vasculitic lesions warrant malignancy screening 2
- Fulminant vasculitis, though rare, can be the presenting feature of lymphoma and carries high mortality 3
Treatment Implications
The presence of underlying lymphoma fundamentally changes management. While standard UV treatment follows a stepwise approach with antihistamines, omalizumab, and immunomodulators 6, lymphoma-associated vasculitis requires treating the underlying malignancy 1. Immunosuppression without addressing the malignancy can be harmful and ineffective 1.